The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin,Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus
Restricted accessResearch articleFirst published online September, 2004
The Role of α1- and α2-Adrenoreceptors on Venlafaxineinduced Elevation of Extracellular Serotonin,Noradrenaline and Dopamine Levels in the Rat Prefrontal Cortex and Hippocampus
The role of adrenergic α1- and α2-adrenoreceptors in augmentation of venlafaxine-induced elevation of extracellular serotonin (5-HT),noradrenaline (NA) and dopamine (DA) levels in the rat prefrontal cortex (PFC) and hippocampus (HIPP) was studied by in vivo microdialysis in anaesthetized rats. The α1-adrenoreceptor antagonist prazosin given alone (0.3 mg/kg, s.c.) induced only a moderate reduction of hippocampal 5-HT and NA levels. The α2-adrenoreceptor antagonistidazoxan (1.5 mg/kg, s.c.) causes moderate increases in the levels of 5-HT and DA in the PFC. The mixed 5-HT and NA reuptake inhibitor venlafaxine (10 mg/kg, i.p.) increased the efflux of 5-HT, NA and DA almost equally, to approximately 200% of the control levels in the PFC. The levels of 5-HT increased to 310%, an effect approximately twice the effect on NA in the HIPP. Venlafaxine also produced a moderate increase in DA levels in the PFC but had no effect in the HIPP. Pre-treatment with prazosin caused a significant attenuation of the venlafaxine induced 5-HT effect in the PFC, and a moderate increase in DA levels in the HIPP. Prazosin had no significant effect on the venlafaxine-induced increase of the NA levels in PFC or HIPP. A combined treatment of venlafaxine with idazoxan increased the venlafaxine NA and DA effects in PFC by a factor of two and resulted in a very robust five-foldaugmentation of NA and DA concentrations in the HIPP. In summary, idazoxan was found to produce a potent enhancement of the venlafaxine effect to increase extracellular NA and DA levels in the PFC and, inparticular, in the HIPP. Idazoxan had no effect on venlafaxine-induced elevation of extracellular 5-HT levels in either PFC or HIPP and prazosin induced a decrease of 5-HT in the PFC. The present data suggest that blockade of α2-adrenoreceptors may play an important role inaugmentation of the effects of mixed monoamine reuptake inhibitors.
Adell A , Artigas F (1999) Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents . Eur J Neurosci11: 2305–2311
2.
Amargos-Bosch M , Adell A , Bortolozzi A , Artigas F (2003) Stimulation of alpha1-adrenoceptors in the rat medial prefrontal cortex increases the local in vivo 5-hydroxytryptamine release: reversal by antipsychotic drugs . J Neurochem87: 831–842
3.
Artigas F , Perez V , Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors . Arch Gen Psychiatry51: 248–251
4.
Artigas F , Romero L , de Montigny C , Blier P (1996) Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists . Trends Neurosci19: 378–383
5.
Bel N , Artigas F (1996) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function. Microdialysis studies . J Pharmacol Exp Ther278: 1064–1072
6.
Bengtsson H J , Kele J , Johansson J , Hjorth S (2000) Interaction of the anti-depressant mirtazapine with alpha2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo . Naunyn Schmiedebergs Arch Pharmacol362: 406–412
7.
Benkert O , Grunder G , Wetzel H , Hackett D (1996) A randomised, double-blind comparison of a arpidly escalati venlafaxine and imipramine in patients with major depress melancholia . J Psychiatr Res30: 441–451
8.
Beyer C E , Boikess S , Luo B , Dawson L A (2002) Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study . J Psychopharmacol16: 297–304
9.
Blier P (2003) The pharmacology of putative early onset antidepressant strategies . Eur Neuropsychopharmacol13: 57–66
10.
Blier P , de Montigny C , Chaput Y (1987) Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression . J Clin Psychopharmacol7: 24S-35S
11.
Bortolozzi A , Artigas F (2003) Control of 5-hydroxytryptamine release in the dorsal raphe nucleus by the noradrenergic system in rat brain. Role of alpha-adrenoceptors . Neuropsychopharmacology28: 421–434
12.
Carboni E , Tanda G L , Frau R , Di Chiara G (1990) Blockade of the nora-drenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by nora-drenergic terminals . J Neurochem55: 1076–1070
13.
Dawson L A , Nguyen H Q , Geiger A (1999) Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism . Neuro-pharmacology38: 1153–1163
14.
de Boer T H , Nefkens F , van Helvoirt A , van Delft A M (1996) Differences in modulation of noradrenergic and serotonergic transmission by the alpha-2 adrenoceptor antagonists, mirtazapine, mianserin and idazoxan . J Pharmacol Exp Ther277: 852–860
15.
Dennis T , L'Heureux R , Carter C , Scatton B (1987) Presynaptic alpha-2 adrenoreceptors play a major role in the effects of idazoxan on cortical noradrenaline release (as measured by in vivo dialysis) in the rat . J Pharmacol Exp Ther241: 642–649
16.
Devoto P , Flore G , Pani L , Gessa G L (2001) Evidence for co-realease of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex . Mol Psychiatry6: 657–664
17.
Devoto P , Flore G , Longu G , Pira L , Gessa G L (2003) Origin of extracellular dopamine from dopamine and noradrenaline neurons in themedial prefrontal and occipital cortex . Synapse50: 200–205
18.
Drevets W C (2000) Neuroimaging studies of mood disorders: implications for a neural model of major depression . Biol Psychiatry48: 813–829
19.
Drevets W C (2001) Neuroimaging and neuropathological studies of depression: implications for the cognitive/emotional manifestations of mood disorders . Curr Opinion Neurobiol11: 240–249
20.
Frankhuyzen A L , Mulder A H (1982) Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat . Eur J Pharmacol81: 97–106
21.
Gartside S E , Umbers V , Sharp T (1997) Inhibition of 5-HT cell firing in the DRN by non-selective 5-HT reuptake inhibitors: studies on the role of 5-HT1A autoreceptors and noradrenergic mechanisms . Psycho-pharmacology130: 261–268
22.
Gobert A , Millan M J (1999) Serotonin (5-HT)2A receptor activation enhances dialysate level of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely moving rats . Neuropharmacology38: 315–317
23.
Gobert A , Lejeune F , Rivet J M , Audinot V , Newman-Tancredi A , Millan M J (1995) Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats . J Pharmacol Exp Ther273: 1032–1046
24.
Gobert A , Rivet J M , Cistarelli L , Melon C , Millan M J (1997) Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats . J Neurochem69: 2616–2619
25.
Gobert A , Rivet J M , Audinot V , Newman-Tancredi A , Cistarelli L , Millan M J (1998) Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single PFC dialysates of freely moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor mediated control of release . Neuroscience84: 413–429
26.
Gresch P J , Sved A F , Zigmond M J , Finlay J M (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex . J Neurochem65: 111–116
27.
Guelfi J D (1995) Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia . J Clin Psychiatry56: 450–458
28.
Hertel P , Nomikos G G , Schilstrom B , Arborelius L , Svensson T H (1997) Risperidone dose-dependently increases extracellular concentrations of serotonin in the rat frontal cortex: role of alpha 2-adrenoceptor antagonism . Neuropsychopharmacology17: 44–55
29.
Hertel P , Fagerquist M V , Svensson T H (1999a) Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade . Science286: 105–107
30.
Hertel P , Nomikos G G , Svensson T H (1999b) Idazoxan preferentially increases dopamine output in the rat medial prefrontal cortex at the nerve terminal level . Eur J Pharmacol371: 153–158
31.
Hertel P , Nomikos G G , Svensson T H (1999c) The antipsychotic drug risperidone interacts with auto- and hetero-receptors regulating serotonin output in the rat frontal cortex . Neuropharmacology38: 1173–1182
32.
Hertel P , Lindblom N , Nomikos G G , Svensson T H (2001) Receptor-mediated regulation of serotonin output in the rat dorsal raphe nucleus: effects of risperidone . Psychopharmacology (Berl)153: 307–314
33.
Hjorth S , Bengtsson H J , Milano S , Lundberg J F , Sharp T (1995) Studies on the role of 5-HT1A autoreceptors and alpha 1-adrenoceptors in the inhibition of 5-HT release – I. BMY7378 and prazosin . Neuro-pharmacology34: 615–620
34.
Hjorth S , Bengtsson H J , Kullberg A , Carlzon D , Peilot H , Auerbach S B (2000) Serotonin autoreceptor function and antidepressant drug action . J Psychopharmacol14: 177–185
35.
Invernizzi R W , Parini S , Sacchetti G , Fracasso C , Caccia S , Annoni K (2001) Chronic treatment with reboxetine by osmotic pumps facilitates its effect on extracellular noradrenaline and may desensitize a2-adrenoceptors in the prefrontal cortex . Br J Pharmacol132: 183–188
36.
Jones L S , Gauger L L , Davis J N (1985) Anatomy of brain alpha 1-adrenergic receptors: in vitro autoradiography with [125I]-heat . J Comp Neurol231: 190–208
37.
Kehr J (1999) Monitoring chemistry of brain microenvironment: biosensors, microdialysis and related techniques. In Windhorst U , Johansson H (eds), Modern techniques in neuroscience research (chapter 41). Springer-Verlag GmbH, Heidelberg
38.
Lee A , Rosin D L , Van Bockstaele E J (1998a) Ultrastructural evidence for prominent postsynaptic localization of alpha2C-adrenergic receptors in catecholaminergic dendrites in the rat nucleus locus coeruleus . J Comp Neurol394: 218–229
39.
Lee A , Wissekerke A E , Rosin D L , Lynch K R (1998b) Localization of a 2c adrenergic receptor immunoreactivity in catecolaminergic neurons in the rat central nervous system . Neuroscience84: 1085–1096
40.
Leinonen E , Skarstein J , Behnke K , Agren H , Helsdingen J T (1999) Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder . Int Clin Psychopharmacol14: 329–337
41.
Linner L , Arborelius L , Nomikos G G , Bertilsson L , Svensson T H (1999) Locus coeruleus neuronal activity and noradrenaline availability in the frontal cortex of rats chronically treated with imipramine: effect of alpha 2-adrenoceptor blockade . Biol Psychiatry46: 766–774
42.
Massana J , Moller H J , Burrows G D , Montenegro R M (1999) Reboxetine: a double-blind comparison with fluoxetine in major depressive disorder . Int Clin Psychopharmacol14: 73–80
43.
Mateo Y , Fernandez-Pastor B , Meana J J (2001) Acute and chronic effects of desipramine and clorgyline on alpha(2)-adrenoceptors regulating noradrenergic transmission in the rat brain: a dual-probe microdialysis study . Br J Pharmacol133: 1362–1370
44.
Mayberg H S (1997) Limbic-cortical dysregulation: a proposed model of depression . J Neuropsychiatry Clin Neurosci9: 471–481
45.
Mayberg H S , Liotti M , Brannan S K , McGinnis S , Mahurin R K , Jerabek P A , Silva J A , Tekell J L , Martin C C , Lancaster J L , Fox P T (1999) Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness . Am J Psychiatry156: 675–682
46.
Mazei M S , Pluto C P , Kirkbride B , Pehek E A (2002) Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat . Brain Res17: 58–67
47.
Millan M J , Gobert A , Rivet J M , Adhumeau-Auclair A , Cussac D , Newman-Tancredi A , Dekeyne A , Nicolas J P , Lejeune F (2000a) Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram . Eur J Neurosci12: 1079–1095
48.
Millan M J , Lejeune F , Gobert A , Brocco M , Auclair A , Bosc C , Rivet J M , Lacoste J M , Cordi A , Dekeyne A (2000b) S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine . J Pharmacol Exp Ther295: 1206–1222
49.
Millan M J , Gobert A , Lejeune F , Newman-Tancredi A , Rivet J M , Auclair A , Peglion J L (2001) S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine . J Pharmacol Exp Ther298: 565–580
50.
Mongeau R P , Blier de Montigny C (1997) The serotonergic and noradrenergic system of the hippocampus: their interactions and the effects of antidepressant treatments . Brain Res Rev23: 145–195
51.
Montgomery S A (1995) Rapid onset of action of venlafaxine . Int Clin Psychopharmacol10 (Suppl 2): 21–27
52.
Montgomery S A (1999) Predicting response: noradrenaline reuptakeinhibition . Int Clin Psychopharmacol14 (Suppl 1): S21–S26
53.
Muth E A , Haskins J T , Moyer J A , Husbands G E , Nielsen S T , Sigg E B (1986) Antidepressant biochemical profile of the novel bicycliccompound Wy-45, 030, an ethyl cyclohexanol derivative . Biochem Pharmacol15: 4493–4497
54.
Muth E A , Moyer J A , Haskins J T , Andree T H , Husbands G E M (1991) Biochemical, neurophysiological, and behavioural effects of Wy-45 233 and other identified metabolites of the antidepressant venlafaxine . Drug Dev Res23: 191–199
55.
Nicholas A P , Hökfelt T , Pieribone V A (1996) The distribution and significance of CNS adrenoreceptors examined with in sity hybridization . Trends Pharmacol Sci17: 245–255
56.
Paxinos G , Watson C (1997) The rat brain in stereotaxic co-ordinates. Academic Press, New York
57.
Pudovkina O L , Cremers T I , Westerink B H (2003) Regulation of the release of serotonin in the dorsal raphe nucleus by alpha1 and alpha2 adrenoceptors . Synapse50: 77–82
58.
Rouquier L , Claustre Y , Benavides J (1994) Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study . Eur J Pharmacol261: 59–64
59.
Sacchetti G , Bernini M , Bianchetti A , Parini S , Invernizzi R W , Samanin R (1999) Study on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brainBr J Pharmacol128: 1332–1338
60.
Smith D , Dempster C , Glanville J , Freemantle N , Anderson I (2002) Efficacy and tolerability of venlafaxine compared with selective serotonin reuptake inhibitors and other antidepressants: a meta-analysis . Br J Psychiatry180: 396–404
61.
Svensson T H , Bunney B S , Aghajanian G K (1975) Inhibition of both nora-drenergic and serotonergic neurons in brain by the alpha-adrenergic agonist clonidine . Brain Res92: 291–306
62.
Tanda G , Frau R , Di Chiara G (1994) Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex . Psychopharmacology (Berl)115: 285–288
63.
Wong D T , Bymaster F P (2002) Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?Prog Drug Res58: 169–222
64.
Wortley K E , Heal D J , Stanford S C (1999) Modulation of sibutramineinduced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors . Br J Pharmacol128: 659–666
65.
Yamaguchi M , Yoshitake T , Fujino K , Kawano K , Kehr J , Ishida J (1999) Determination of norepinephrine in microdialysis samples by micro-bore column liquid chromatography with fluorescence detection following derivatization with benzylamine . Anal Biochem270: 296–302
66.
Yamamoto B K , Novotney S (1998) Regulation of extracellular dopamine by the norepinephrine transporter . J Neurochem71: 274–280
67.
Xu K , Naveri L , Frerichs K U , Hallenbeck J M , Feuerstein G , Davis J N , Siren A L (1993) Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals . J Pharmacol Exp Ther267: 211–217
68.
Zang W , Perry K W , Wong D T , Potts B D , Bao J , Tollefson G D (2000) Synergistic effect of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex . Neuropsychopharmacology23: 250–262
